Douglas T. Sheehy, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 58,761 shares at $33.25 ($2.0M) on 2017-10-23, disclosed to the SEC on 2017-10-25.
Open-market sale of $2.0M AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.25 | 22,964 | $764K | 37.7% |
| 2 | $34.13 | 5,003 | $171K | 8.4% |
| 3 | $34.13 | 5,003 | $171K | 8.4% |
| 4 | $35.34 | 6,333 | $224K | 11.0% |
| 5 | $35.34 | 6,333 | $224K | 11.0% |
| 6 | $35.63 | 7,500 |
| $267K |
| 13.2% |
| 7 | $37.00 | 5,625 | $208K | 10.3% |
| Total | $34.51 avg | 58,761 | $2.0M | 100% |
| Filing → |
| AIMT | SELL | 2018-05-24 | $54K | — | Filing → |
| AIMT | SELL | 2018-03-06 | $129K | — | Filing → |
| AIMT | SELL | 2018-02-07 | $118K | — | Filing → |